352
Participants
Start Date
October 28, 2014
Primary Completion Date
June 19, 2018
Study Completion Date
June 19, 2018
Laquinimod
Laquinimod capsules will be administered as per the dose and schedule specified in the respective arms.
Placebo
Matching laquinimod placebo will be administered as per the schedule specified in the respective arms.
Teva Investigational Site 31097, Barcelona
Teva Investigational Site 31110, Barcelona
Teva Investigational Site 12570, New York
Teva Investigational Site 32480, Berlin
Teva Investigational Site 54108, Prague
Teva Investigational Site 12569, Rochester
Teva Investigational Site 30098, Milan
Teva Investigational Site 30100, Milan
Teva Investigational Site 31131, Madrid
Teva Investigational Site 13490, Tampa
Teva Investigational Site 13325, Nashville
Teva Investigational Site 13489, Memphis
Teva Investigational Site 30168, Bologna
Teva Investigational Site 31187, Seville
Teva Investigational Site 32482, Bochum
Teva Investigational Site 32481, Münster
Teva Investigational Site 31185, Barakaldo
Teva Investigational Site 13326, Iowa City
Teva Investigational Site 12571, Golden Valley
Teva Investigational Site 12572, St Louis
Teva Investigational Site 12568, Wichita
Teva Investigational Site 30099, San Giovanni Rotondo
Teva Investigational Site 12815, Houston
Teva Investigational Site 12575, Englewood
Teva Investigational Site 30097, Napoli
Teva Investigational Site 32483, München
Teva Investigational Site 32479, Ulm
Teva Investigational Site 12565, Los Angeles
Teva Investigational Site 32618, Erlangen
Teva Investigational Site 12566, La Jolla
Teva Investigational Site 12567, San Francisco
Teva Investigational Site 12576, Kirkland
Teva Investigational Site 50380, Moscow
Teva Investigational Site 50379, Kazan'
Teva Investigational Site 50381, Nyznij Novgorod
Teva Investigational Site 12574, Baltimore
Teva Investigational Site 11080, Vancouver
Teva Investigational Site 11118, Ottawa
Teva Investigational Site 11079, Toronto
Teva Investigational Site 11124, Edmonton
Teva Investigational Site 38066, Leiden
Teva Investigational Site 36026, Lisbon
Teva Investigational Site 31186, Burgos
Teva Investigational Site 34176, Aberdeen
Teva Investigational Site 34177, Birmingham
Teva Investigational Site 34194, Liverpool
Teva Investigational Site 34179, London
Teva Investigational Site 34209, London
Teva Investigational Site 34204, London
Teva Investigational Site 34203, London
Teva Investigational Site 34175, Manchester
Teva Investigational Site 34215, Newcastle upon Tyne
Teva Investigational Site 34216, Sheffield
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY